Mimetas
Latest round
- Series B
Last raised
- Apr 2018
Total raised
- $21M
Investors
- 6
About Mimetas
V.V. develops 3D tissue models for drug discovery. The company's founders, Jos Joore, Paul Vulto, and Thomas Hankemeier, have extensive backgrounds in biotechnology.Mimetas specializes in advanced human tissue models that enhance drug discovery and development processes. Their flagship product, the OrganoPlate®, utilizes a proprietary platform to create robust assays for various therapeutic areas, including cancer and immunology.Mimetas generates revenue through a fee-for-service model, providing customized solutions to clients in the pharmaceutical and biotech sectors. The company engages in business-to-business transactions, with clients paying for the use of their OrganoReady program, which offers optimized assays for investigational toxicology.Mimetas plans to launch new products tailored to meet the evolving needs of drug discovery, with specific details on release dates yet to be disclosed. The company aims to expand its market presence in North America and Europe, targeting these regions with their innovative tissue models.00 mn, will be utilized to support these initiatives, enhancing their capabilities in providing specialized solutions for preclinical research.
Who invested in Mimetas
6 investors across 1 round
See all investors in Mimetas
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Apr 11, 2018
Amount
$21M
Investors
Questions about Mimetas
Who invested in Mimetas?
Mimetas has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Mimetas raised?
Mimetas has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Mimetas last raise money?
Mimetas's most recent round on record is a Series B, in Apr 2018.
What does Mimetas do?
Mimetas is a biotechnology company.
Where is Mimetas headquartered?
Mimetas is headquartered in Leiden, Netherlands.
Which VCs invest in companies like Mimetas?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Mimetas's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Mimetas? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.